BB vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

BB

46.2
AI Score
VS
BB Wins

CLOV

34.3
AI Score

Investment Advisor Scores

BB

46score
Recommendation
HOLD

CLOV

34score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BB CLOV Winner
Revenue 152.90M 1.49B CLOV
Net Income 8.50M 55.34M CLOV
Net Margin 5.6% 3.7% BB
Operating Income 15.30M 55.34M CLOV
ROE 1.1% 14.7% CLOV
ROA 0.7% 7.7% CLOV
Total Assets 1.24B 720.33M BB
Current Ratio 2.20 1.50 BB
Free Cash Flow 1.70M 131.55M CLOV

Relative Price Performance (Last 90 Days)

BB 1M: -6.8% · 3M: +20.9% CLOV 1M: -8.8% · 3M: +15.3%

Current Technical Phase

BB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 37

RSI (14): 36.8 · Price: $8.04

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.8 · Price: $4.15

Fundamentals Snapshot

Metric BB CLOV
Market Cap
Forward P/E 48.9 27.7
Trailing P/E 80.5
Revenue (TTM)
Revenue Growth 0.3% 0.6%
Gross Margin 0.8% 0.2%
Operating Margin 0.1% 0.0%
EPS 0.10 -0.05
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BB is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.